BRIEF-Genmab: FDA approves Arzerra for treatment of relapsed chronic lymphocytic leukemia
August 31, 2016 at 05:20 AM EDT
* FDA approved a supplemental biologics license application for use of ofatumumab
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.